Characterizing Salmonella Typhimurium-induced Septic Peritonitis in Mice
July 29th, 2022
5.2K views
This protocol describes the induction of Gram-negative monobacterial sepsis in a mouse model system. The model is useful in investigating the inflammatory and lethal host responses during sepsis.
Overview
This protocol describes the induction of Gram-negative monobacterial sepsis in a mouse model system. This model is useful in investigating the inflammatory and lethal host responses during sepsis.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Infectious Diseases
Background
- Sepsis is a dysregulated immune response to microbial invasion.
- It can lead to organ injury distant from the infection site.
- In 2017, there were 48.9 million sepsis incidences worldwide.
- Gram-negative organisms are commonly found in sepsis cases in ICUs.
Purpose of Study
- To investigate the inflammatory responses during sepsis.
- To understand lethal host responses in a controlled model.
- To provide insights into sepsis mechanisms for future therapeutic strategies.
Methods Used
- Induction of Gram-negative monobacterial sepsis in mice.
- Monitoring of inflammatory responses.
- Assessment of host responses to sepsis.
- Comparison with other sepsis models.
Main Results
- Demonstrated the utility of the monobacterial model for studying sepsis.
- Identified key inflammatory markers associated with sepsis.
- Showed differences in host responses compared to other models.
- Provided a framework for future sepsis research.
Conclusions
- The Gram-negative monobacterial sepsis model is effective for research.
- It helps in understanding the complexities of sepsis.
- Future studies can build on this model to explore therapeutic options.
Frequently Asked Questions
What is sepsis?
Sepsis is a severe response to infection that can lead to tissue damage and organ failure.
Why use a mouse model for sepsis research?
Mouse models allow for controlled studies of sepsis mechanisms and host responses.
What are common causes of sepsis?
Sepsis is often caused by bacterial infections, particularly gram-negative bacteria.
How prevalent is sepsis globally?
In 2017, there were approximately 48.9 million cases of sepsis worldwide.
What are the implications of sepsis research?
Research can lead to better understanding and treatment options for sepsis.
What are the key inflammatory markers in sepsis?
Key markers include cytokines and other immune response indicators.
How does this model compare to other sepsis models?
This model provides unique insights that differ from LPS-induced or cecal ligation models.
Executive Industry Relevance
Robust animal models of Gram-negative sepsis are critical for de-risking early immunology and anti-infective programs. The Salmonella Typhimurium-induced septic peritonitis model enables quantitative assessment of host-pathogen interactions, immune cell dynamics, and systemic inflammatory responses. This platform supports predictive confidence in target validation and translational continuity for immunomodulatory and anti-infective R&D portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of immune response pathways and gene function during acute sepsis.
- Supports biological de-risking by modeling clinically relevant Gram-negative infection.
- Facilitates functional target validation through quantitative immune cell and cytokine readouts.
- Provides mechanistic insight for portfolio triage of immunomodulatory targets.
Screening & Assay Development
- Delivers reproducible, standardized infection and immune response conditions for downstream assays.
- Enables quantitative measurement of bacterial burden and immune cell infiltration for assay development.
- Supports screening of candidate therapeutics for efficacy in modulating sepsis outcomes.
- Establishes platform readiness for scalable compound evaluation in vivo.
Translational & Preclinical Research
- Aligns with disease-relevant mechanisms observed in human Gram-negative sepsis.
- Provides continuity from discovery through preclinical validation of immunological interventions.
- Enables risk-adjusted advancement decisions based on systemic and organ-specific readouts.
- Supports translational biomarker identification through flow cytometric and cytokine analyses.
Pipeline & Workflow Integration
This model bridges early discovery, target validation, and preclinical efficacy assessment for anti-infective and immunology programs.
- Discovery Biology: Quantifies immune cell dynamics and cytokine responses to interrogate host-pathogen interactions.
- Screening: Provides standardized, reproducible infection and immune response metrics for candidate evaluation.
- Analytics: Enables quantitative bacterial burden, neutrophil infiltration, and cytokine measurement for comparative analysis.
- Translational Research: Aligns with clinical sepsis features, supporting biomarker and mechanistic studies.
- Enterprise Reuse: Functions as a reusable in vivo platform for diverse immunology and anti-infective research initiatives.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in sepsis research.
- Operational Value: Delivers standardized, reproducible, and scalable in vivo workflows.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by de-risking early targets.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of immunomodulatory and anti-infective assets.
Implementation Considerations
- Requires expertise in murine infection models and immunological assays.
- Necessitates BSL-2 facility, PPE, and adherence to biohazard protocols.
- Demands cross-team standardization of infection, sampling, and analytical procedures.
- Adaptable to different genetic backgrounds and therapeutic interventions as supported by the protocol.
- Practical limitations include animal welfare, facility requirements, and model-specific mortality rates.
Biopharma FAQs
Why does null hypothesis testing matter for neutrophil infiltration analysis?
Null hypothesis testing in flow cytometric neutrophil analysis ensures that observed increases in cell populations are statistically significant, supporting robust target validation and reducing false positives in immune response studies.
How does independent variable isolation fit in bacterial burden quantification?
Isolating the independent variable, such as infection dose, in organ CFU quantification enables clear attribution of observed effects to experimental manipulations, strengthening mechanistic insights and discovery-stage decision making.
What do quantitative dependent variable measurements enable in this sepsis model?
Quantitative measurements of bacterial load and immune cell infiltration provide actionable data for comparing interventions, optimizing dosing, and benchmarking candidate efficacy in translational research workflows.
Why are replication requirements critical for cross-functional sepsis studies?
Replication ensures reproducibility of immune and infection readouts, enabling reliable cross-team data integration and supporting enterprise-wide confidence in preclinical findings.
What statistical analysis capabilities are required before implementing cytokine profiling?
Robust statistical analysis, including group comparisons and significance testing, is essential for interpreting cytokine profiling data and informing go/no-go decisions in immunology and anti-infective R&D pipelines.
